Evotec (NASDAQ:EVO) stock is taking a beating on Wednesday following the release of the company’s earnings report for the full year of 2023!
Evotec is sliding lower today alongside the company’s outlook for 2024. This has it expecting double-digit revenue growth compared to 2023’s 781.4 million euros. RBC Capital notes this is “significantly more cautious” than what experts are predicting for 2024 revenue.
The company’s 2023 revenue of 781.4 million euros has also failed to impress investors. That’s lower than the 782 million euros that Wall Street was expecting for the year, even if it’s up 8% compared to the 751.4 million euros reported in 2022.
Evotec interim CEO Mario Polywka said the following in the earnings report:
“Our central focus for 2024 is to protect our strong balance sheet and refocus the Company on profitable growth. Through the planned priority reset and measures to rightsize our operational and corporate structure, we are taking the necessary steps to ensure that we continue to work with our partners to shape the medicines that matter for many years to come.”
More EVO Stock New
Alongside this earnings report comes the announcement of a new CEO for Evotec. Christian Wojczewski will be taking over as the next CEO of the company when July starts. This ends the search for a new CEO that started in January.
EVO stock is down 33.1% as of Wednesday morning.
There are more stock market stories available below!
We have all of the hottest stock market news ready to go on Wednesday! A few examples include what’s happening with Zapata Computing (NASDAQ:ZPTA), PHX Minerals (NYSE:PHX) and Chicken Soup for the Soul (NASDAQ:CSSE) stock this morning. All of that news is good to go at the following links!
More Wednesday Stock Market News
- Why Is Zapata Computing (ZPTA) Stock Up 17% Today?
- Trade of the Day: PHX Minerals (PHX) Stock Is a Hidden-Gem Buy
- Why Is Chicken Soup for the Soul (CSSE) Stock Up 84% Today?
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
